Rational identification of Corynebacterium strains for use as probiotics
Rational identification of Corynebacterium strains for use as probiotics
批准号:
10622610
负责人:
Matthew Scott Kelly
金额:
$19.43万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-16 至 2025-04-30
关键词:
AccountingAdherenceBacteremiaBacteriaBacterial PneumoniaBiological Response Modifier TherapyCandidate Disease GeneCellsCessation of lifeChildChild MortalityChildhoodComparative Genomic AnalysisCompetitive BindingCorynebacteriumDataDefensinsDevelopmentDiseaseEpithelial AttachmentEpitheliumExclusionExhibitsFutureGenesGeneticGenomicsGenotypeGoalsGrowthHumanIn VitroInfectionInfection preventionInterventionInvadedKnowledgeLow PrevalenceLower respiratory tract structureMediatingMeningitisModelingNasopharynxPathogenicityPeptidesPhenotypePneumococcal InfectionsPneumoniaPreventionProbioticsProteomicsResearchRespiratory SystemRespiratory Tract InfectionsRiskSerotypingSkinStreptococcus pneumoniaeSurfaceTestingTissue ModelUpper respiratory tractVaccinationVaccinesWorkairway epitheliumantimicrobialantimicrobial peptidebacterial resistancebiobankcolonization resistancecomparativecomparative genomicsexperimental studygenome annotationgenome sequencinginfection riskinsightmicrobiotamortalitynovelpan-genomepathogenpathogenic bacteriapatient populationpreventrational designrepositoryrespiratoryrespiratory colonizationrespiratory pathogentherapeutic candidatewhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Pneumonia is the leading infectious killer of children. Bacterial pathogens, particularly Streptococcus
pneumoniae, cause the most serious disease and mortality. Vaccination reduces invasive diseases such as
bacteremia and meningitis caused by vaccine serotypes. However, vaccination does not equally lower the
burden of pneumonia, and non-vaccine S. pneumoniae serotypes continue to emerge to cause respiratory and
invasive infections. Thus, an opportunity exists for new ways to prevent these infections.
Nasopharyngeal colonization precedes bacterial pneumonia and other respiratory infections, and the microbiota
serves as a barrier to pathogen colonization and subsequent invasion of the lower respiratory tract. Our studies
and others demonstrate that commensal, non-pathogenic Corynebacterium species are associated with a lower
prevalence of colonization by bacterial respiratory pathogens, including S. pneumoniae. The data show an
inverse correlation between the relative abundance of Corynebacterium in the nasopharyngeal microbiota and
the risk of colonization by S. pneumoniae. These Corynebacterium species may be promising biotherapeutic
candidates for development if they exert specific mechanistic control of bacterial respiratory pathogens.
The overall objective herein is to identify the mechanisms by which Corynebacterium spp. colonize the human
nasopharynx and exclude S. pneumoniae colonization. The rationale is that defining the mechanisms of these
interspecies interactions will lead to identifying Corynebacterium spp. that exert multiple mechanisms of
pathogen exclusion and are candidates for future biotherapeutics to prevent respiratory infections.
The Specific Aims are: 1) Identify mechanisms by which Corynebacterium spp. adhere to the respiratory
epithelium and inhibit Sp colonization through competitive adherence, and 2) Elucidate non-adherence
mechanisms by which Corynebacterium spp. inhibit Sp colonization. This proposal will combine models of
bacteria-host and bacteria-bacteria interactions to define mechanisms through which Corynebacterium inhibit S.
pneumoniae colonization. We will leverage comparative genomics of a large Corynebacterium strain repository
to identify accessory gene candidates that mediate respiratory epithelium attachment, competitive adherence
with S. pneumoniae, and pneumococcal growth inhibition through secreted factors.
The impact of this work is expected from the mechanistic insights and Corynebacterium strain identification
that may lead to the first rationally-designed biotherapeutics to prevent pneumonia and other respiratory
infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host-microbe interactions and SARS-CoV-2 susceptibility and symptoms in a novel human challenge model
-
批准号:10724669
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2023
-
负责人:Matthew Scott Kelly
-
依托单位:
Rational identification of Corynebacterium strains for use as probiotics
-
批准号:10453307
-
项目类别:
-
资助金额:$24.51万
-
财政年份:2022
-
负责人:Matthew Scott Kelly
-
依托单位:
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants
-
批准号:10159201
-
项目类别:
-
资助金额:$16.23万
-
财政年份:2018
-
负责人:Matthew Scott Kelly
-
依托单位:
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants
-
批准号:10386926
-
项目类别:
-
资助金额:$14.35万
-
财政年份:2018
-
负责人:Matthew Scott Kelly
-
依托单位:
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants
-
批准号:9598639
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2018
-
负责人:Matthew Scott Kelly
-
依托单位:
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants
-
批准号:9919494
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2018
-
负责人:Matthew Scott Kelly
-
依托单位:
海外基金